In this study, CQ was able to inhibit the A.2.5 variant infection in Calu-3 cells, although at a lower level (two-fold less) compared to the TMPRSS2 inhibitor camostat (CAM) (Dittmar et al., 2021). This evidence concerns the gene TMPRSS2 and infection.